Cephalosporins
- PMID: 31643977
- Bookshelf ID: NBK548666
Cephalosporins
Excerpt
The cephalosporins are a family of bactericidal antibiotics structurally related to penicillin which were first derived from the fungus, Cephalosporum acremonium. Their basic structure is similar to penicillin with a thiazolidine and beta-lactam ring, which has a variable side chain. Cephalosporins bind to the penicillin-binding proteins on bacteria and inhibit synthesis of the bacterial cell wall, causing cell lysis particularly in rapidly growing organisms. Their differences in activity relate to the range of penicillin-binding proteins that they inhibit. They have a broader activity than the standard penicillins, but are also sensitive to some extent to beta-lactamase. Five generations of cephalosporins have been developed with varying antibacterial activity. Cephalosporins are indicated for infections with susceptible organisms of various tissues and organs. Cephalosporins have variable oral absorption and many must be given parenterally. The oral preparations are used largely for mild and moderate infections; the parenteral forms for more severe infections and sepsis. In the lists below, formulations that are available in oral and parenteral forms are shown separately. Some of these formulations have been discontinued and are no longer available in the United States.
First generation cephalosporins include cefadroxil, cefazolin, cephalexin, and cephradine, and these are active against many gram-positive cocci, including penicillinase-producing Staphylococcus aureus.
Second generation cephalosporins include cefaclor, cefoxitin, cefprozil, cefonicid, and cefuroxime; these have broader antibacterial activity, and additional sensitive organisms including Citrobacter, Enterobacter, Haemophilus influenzae, Neisseria and Serratia species.
Sections
Similar articles
-
Penicillins (4th Generation).2020 Oct 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2020 Oct 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643749 Free Books & Documents. Review.
-
Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.Infection. 1991 Sep-Oct;19(5):353-62. doi: 10.1007/BF01645369. Infection. 1991. PMID: 1800377
-
Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.Clin Ther. 2003 Jan;25(1):169-77. doi: 10.1016/s0149-2918(03)90021-x. Clin Ther. 2003. PMID: 12637118
-
Review of the in vitro antibacterial activity of cefprozil, a new oral cephalosporin.Clin Infect Dis. 1992 Jun;14 Suppl 2:S189-94; discussion S195-6. doi: 10.1093/clinids/14.supplement_2.s189. Clin Infect Dis. 1992. PMID: 1617037 Review.
-
[Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].Infection. 1990;18 Suppl 3:S155-67. doi: 10.1007/BF01644637. Infection. 1990. PMID: 2079378 German.
References
-
- Zimmerman HJ. Cephalosporins. In, Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver. 2nd Ed. Philadelphia: Lippincott, 1999. p. 589-92.(Expert review of cephalosporins and liver injury published in 1999; mentions that "cephalosporin use has been relatively free of serious hepatic injury" with rare descriptions of cholestatic injury).
-
- Moseley RH. Hepatotoxicity of antimicrobials and antifungal agents. In, Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 3rd Edition. Amsterdam: Elsevier, 2013. p. 466.(Short review of cephalosporin induced liver injury mentions that hepatotoxicity from cephalosporins is rare and usually resembles penicillin induced liver injury).
-
- Petri WA Jr. Penicillins, cephalosporins, and other ß-lactam antibiotics. In, Brunton LL, Chabner BA, Knollman BC, eds. Goodman & Gilman’s The pharmacological basis of therapeutics, 12th ed. New York: McGraw-Hill, 2011. p. 1477-1504.(Textbook of pharmacology and therapeutics).
-
- Fung-Herrera CG, Mulvaney WP. Cephalexin nephrotoxicity. Reversible nonoliguric acute renal failure and hepatotoxicity associated with cephalexin therapy. JAMA. 1974;229:318–9. [ (70 year old man developed nonoliguric renal failure after 8 days of cephalothin-cephalexin with mild jaundice [2.4 mg/dL, AST 85 U/L, Alk P 276 U/L], resolving within a month of stopping). ] - PubMed
-
- McArthur JE, Dyment PG. Stevens-Johnson syndrome with hepatitis following therapy with ampicillin and cephalexin. N Z Med J. 1975;81:390–2. [ (9 month old boy given ampicillin [developing rash 3 days after stopping] and then cephalexin [developing Stevens-Johnson after 3 days], also developed jaundice [bilirubin 13 mg/dL, ALT 460 U/L, Alk P normal], resolving with prednisone; relative role of cephalexin vs ampicillin was unclear). ] - PubMed
Publication types
LinkOut - more resources
Full Text Sources